IHS Chemical Week

Regions :: North America

Questcor Pharmaceuticals acquires Canadian API firm BioVectra

7:27 AM MST | January 8, 2013 | Deepti Ramesh

Pharmaceutical ingredients manufacturer BioVectra (Charlottetown, PE) says that biopharmaceutical company Questcor Pharmaceuticals (Anaheim Hills, CA) has signed a definitive agreement to acquire all issued and outstanding shares of BioVectra for an upfront payment of C$50 million ($50.7 million). BioVectra is a supplier of contract manufacturing services to the global pharmaceutical and biotechnology industry, and manufactures active pharmaceutical ingredients (API), chemical intermediates, and bioprocessing reagents. BioVectra had sales of about $28 million in...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa